- ►bmj.com [PDF] DD Sin, L Wu, J Anderson, N Anthonisen, AS … - British Medical Journal, 2005 - thorax.bmj.com Online First articles must include the digital object identifier (DOIs) and date
of initial publication. establish publication priority; they are indexed by
PubMed from initial publication. Citations to may be posted when available ... Cited by 208 - Related articles - BL Direct - All 13 versions
S Spencer, PMA Calverley, PS Burge, PW … - European Respiratory Journal, 2004 - ersj.org.uk Exacerbations of chronic obstuctive pulmonary disease (COPD) are associated with
worse health status. The Inhaled Steroids in Obstructive Lung Disease in Europe
(ISOLDE) study showed that treatment with fluticasone propionate (FP) ... Cited by 153 - Related articles - BL Direct - All 7 versions
M Decramer, B Celli, DP Tashkin, RA Pauwels … - COPD: Journal of Chronic Obstructive Pulmonary …, 2004 - informahealthcare.com An accelerated loss of lung function is one of the defining characteristics of
chronic obstructive pulmonary disease (COPD). To date, the only successful
intervention shown to conclusively attenuate the loss of lung function over ... Cited by 110 - Related articles - All 10 versions
- ►chestpubs.org JB Soriano, DD Sin, X Zhang, PG Camp, JA … - Chest, 2007 - chestjournal.chestpubs.org * From the Program of Epidemiology and Clinical Research (Dr. Soriano),
Fundació Caubet-CIMERA Illes Balears, International Centre for Advanced
Respiratory Medicine, Bunyola, Mallorca, Illes Balears, Spain; James Hogg ... Cited by 65 - Related articles - BL Direct - All 9 versions
SI Rennard - The Lancet, 2004 - Elsevier Chronic obstructive pulmonary disease (COPD) is a readily diagnosable disorder
that responds to treatment. Smoking cessation can reduce symptoms and prevent
progression of disease. Bronchodilator therapy is key in improvement of ... Cited by 61 - Related articles - All 12 versions
TJ Wilt, D Niewoehner, R MacDonald, RL … - Annals of Internal Medicine, 2007 - Am Coll Physicians Background: Chronic obstructive pulmonary disease (COPD) is a common and
disabling condition in adults. Information about therapeutic effectiveness and
adverse effects of common treatment options and how clinical and ... Cited by 57 - Related articles - BL Direct - All 12 versions
- ►atsjournals.org BR Celli, NE Thomas, JA Anderson, GT … - American journal of respiratory and critical care …, 2008 - Am Thoracic Soc Measurements and Main Results: Spirometry was measured every 24 weeks for 3
years. There were 26,539 on-treatment observations. The adjusted rate of decline
in FEV 1 was 55 ml/year for placebo, 42 ml/year for salmeterol, 42 ml/year ... Cited by 49 - Related articles - All 5 versions
- ►bmj.com CB Cooper, DP Tashkin - British Medical Journal, 2005 - bmj.com Since therapeutic strategies in COPD and asthma differ markedly, differential
diagnosis is key to optimal management. Asthma should be suspected in patients
with a childhood history of asthma, recurrent respiratory infections or ... Cited by 44 - Related articles - All 9 versions
PJ Barnes - American Journal of Medicine Supplements, 2004 - Elsevier Anticholinergics are the bronchodilators of choice in the management of chronic
obstructive pulmonary disease (COPD). They work by blocking muscarinic receptors
in airway smooth muscle. Cholinergic tone appears to be the only reversible ... Cited by 36 - Related articles - All 13 versions
DE Doherty - American Journal of Medicine Supplements, 2004 - Elsevier Asthma and chronic obstructive pulmonary disease (COPD) are distinct
inflammatory disorders with differing pathophysiologic mechanisms, different
clinical courses, and, therefore, distinct treatment strategies. Whereas in ... Cited by 34 - Related articles - All 12 versions
